Chronic low-grade inflammation also has a major role in vascular aging, potentially leading to various age-related diseases, including cardiovascular diseases
However, an analysis of other secondary endpoints showed that treatment with lixisenatide led to a lower risk of developing new-onset massive albuminuria in patients with T2DM, slowed the progression of diabetic nephropathy in patients with massive albuminuria-associated T2DM, and demonstrated a positive impact on maintaining body weight (Pfeffer et al., 2015)
Precision tracking for your journey Join thousands using Shotlee to accurately track GLP-1 medications and side effects
Healthcare providers can offer guidance on managing these aspects of care to minimize discomfort and maintain treatment efficacy
Younger researchers might benefit from lower doses focused on maintenance rather than correction
Return to the fridge immediately